SEC Company Response from Applied Therapeutics, Inc. (APLT) (CIK 0001697532) — Jan 21, 2020
Applied Therapeutics, Inc. (APLT) (CIK 0001697532)
Date: Jan. 21, 2020 · CIK: 0001697532 · Accession: 0001104659-20-005582
AI Filing Summary & Sentiment
File numbers found in text: 333-235988
Letter
Re:
Applied Therapeutics, Inc.
545 5th Avenue, Suite 1400
New York, New York 10173
January 21, 2020
VIA EDGAR AND EMAIL
Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549
Attn: Jeffrey Gabor
Applied Therapeutics, Inc.
Registration Statement on Form S-1 (File No. 333-235988)
Request for Acceleration of Effective Date
Mr. Gabor:
We refer to the registration statement on Form S-1 (File No. 333-235988) (the “Registration Statement”), of Applied Therapeutics, Inc. (the “Company”), relating to the registration of the Company’s common stock, par value $0.0001 per share.
In accordance with Rules 460 and 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effectiveness of the Registration Statement be accelerated so that it may become effective at 4:30 P.M. (Eastern time) on Tuesday, January 21, 2020, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Please call Andrea L. Nicolas of Skadden, Arps, Slate, Meagher & Flom LLP, at (212) 735-3416, to confirm the effectiveness of the Registration Statement.
Very truly yours,
Applied Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm Applied Therapeutics, Inc. 545 5th Avenue, Suite 1400 New York, New York 10173 January 21, 2020 VIA EDGAR AND EMAIL Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Attn: Jeffrey Gabor Re: Applied Therapeutics, Inc. Registration Statement on Form S-1 (File No. 333-235988) Request for Acceleration of Effective Date Mr. Gabor: We refer to the registration statement on Form S-1 (File No. 333-235988) (the “Registration Statement”), of Applied Therapeutics, Inc. (the “Company”), relating to the registration of the Company’s common stock, par value $0.0001 per share. In accordance with Rules 460 and 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effectiveness of the Registration Statement be accelerated so that it may become effective at 4:30 P.M. (Eastern time) on Tuesday, January 21, 2020, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Please call Andrea L. Nicolas of Skadden, Arps, Slate, Meagher & Flom LLP, at (212) 735-3416, to confirm the effectiveness of the Registration Statement. Very truly yours, Applied Therapeutics, Inc. By: /s/ Shoshana Shendelman Name: Shoshana Shendelman Title: President and Chief Executive Officer (Principal Executive Officer)